Literature DB >> 16322437

Issues in bringing new drugs to the market.

Rudi Ansbacher.   

Abstract

Mesh:

Substances:

Year:  2005        PMID: 16322437     DOI: 10.1126/science.310.5753.1425b

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  1 in total

1.  Clinical Trial Risk in Hepatitis C: Endpoint Selection and Drug Action.

Authors:  Nicole A Tillie; Jayson L Parker; Jordan J Feld
Journal:  Can J Gastroenterol Hepatol       Date:  2016-03-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.